Search results for Chronic Liver Disease Assessment

Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care

The burden of chronic liver disease is rapidly increasing worldwide, driven primarily by metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic and alcohol-ass...

What You Need to Know About Liver Disease

May is Hepatitis Awareness Month.Around 4.5 million adults in the United States are living with chronic liver disease — and women are more likely than men to develop chronic liver...

Su2008 GUT-LIVER AXIS SEPSIS RISK SCORE: PREDICTING SEPSIS AND SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER...

Optimizing the Evaluation of Biomarkers for HCC Surveillance

BMI, insulin markers may improve youth liver disease screening

CHICAGO — Insulin resistance markers and BMI were more effective in detecting steatotic liver disease among adolescents and young adults compared with glycemic and lipid measuremen...

Toward Precision HCC Surveillance: Standardizing Ultrasound Visualization and Optimizing Biomarker Integration

Enhanced Liver Fibrosis (ELF) Test

Enhanced Liver Fibrosis (ELF) Test Explained: An Integrative Ayurvedic Perspective on Liver Health Abstract Liver fibrosis represents a dynamic process ... Read more The post Enhan...

Abstract No. 1 â–ª ABSTRACT OF THE YEAR Factors Impacting Post-TIPS Liver Failure (PTLF): A Retrospective Cohort Study

To identify clinical and laboratory predictors of PTLF.

Not So Fast, My Friend: Biomarkers May Play an Important Role in HCC Surveillance

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: E...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in patients with cirrhosis. Although advancements in surgical, locoregional, and systemic therapies have i...

Binge drinking triples odds for advanced liver fibrosis in MASLD

Episodic heavy drinking is prevalent among individuals with metabolic dysfunction-associated steatotic liver disease and increases risk for advanced liver fibrosis, according to a...

Mortality risk doubled in alcohol-related vs. MASH cirrhosis

CHICAGO — Alcohol-related cirrhosis carries a twofold higher mortality risk than cirrhosis stemming from metabolic dysfunction-associated steatohepatitis, even when disease severit...

Women with key cardiometabolic risks face higher liver fibrosis

Women who have two or more cardiometabolic risk factors were linked to a higher likelihood of significant liver fibrosis compared to men with the same risk factors, according to cr...

IFT140 ADPKD with dominant hepatic cystic disease

A 56-year-old woman presented with several months of abdominal pain and weight loss related to a large hepatic cyst. Her family history was notable for polycystic disease affecting...

Cytokeratin-18 Fragments (M30 / M65)

Cytokeratin-18 Fragments (M30 / M65) – What Is It? Why Is It Done? & Ayurvedic Hepatoprotective Herbs Abstract Chronic liver ... Read more The post Cytokeratin-18 Fragments (M3...

Su2135 CLINICAL EFFICACY OF PROBIOTICS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE - A DOUBLE-BLIND RANDOMIZED PLA...

New study reveals promising new way to find serious liver disease earlier

The method will use existing NHS blood test data to identify people with serious liver disease earlier.

New AI Blood Test Detects Silent Liver Disease Before Symptoms Appear

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin. Scientists at the Johns Hopkins Kimmel Cancer Center have develop...

DCP (Des-gamma-carboxy Prothrombin) / PIVKA-II Test

DCP (Des-gamma-carboxy Prothrombin) / PIVKA-II Test – What Is It? Why Is It Done? Ayurvedic Perspective on Liver Health Abstract ... Read more The post DCP (Des-gamma-carboxy Proth...

Tu2127 TRENDS AND OUTCOMES OF LIVER TRANSPLANT CANDIDATES WITHOUT CLEAR INDICATIONS: A UNOS COHORT ANALYSIS (2002-2024)

Fatty Liver Disease Increases Heart Attack Risk, Study Says

THURSDAY, May 21, 2026 — Fatty liver disease is dangerous for the heart as well as the liver, a new study says. People with fatty liver disease have nearly doubled rates of heart a...

Characteristics of Transient Elastography for Hepatic Steatosis and Fibrosis in Children Undergoing Liver Biopsy

To determine the diagnostic performance of vibration controlled transient elastography (VCTE) measured the same day as liver biopsy in screening and risk stratification of steatosi...

156 THE PLASMA PROTEOME REVEALS PROGNOSTICALLY IMPORTANT MOLECULAR ENDOTYPES IN PEDIATRIC CHOLESTASIS

12 diet changes that may help reduce fatty liver disease naturally

With fatty liver cases rising 50% in two decades, researchers are increasingly pointing to everyday diet habits as both the cause and the cure. Imagine this: your liver, one of you...